Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Drug design/development extension

The special advantages of selective substitution of fluorine in drug design and development are well recognized and have been reviewed extensively [21]. Small size and high electronegativity impart special properties to fluorinated... [Pg.665]

The carbohydrate metabolism of cestodes has been more extensively studied than any other aspect of metabolism it has been the subject of a number of reviews (39,41,101,102,104,129,221,398,490,492,673,698, 759,816, 911, 931). Much work in this area has been aimed at the identification of biochemical steps which might differ substantially from the host metabolism and which may, therefore, be of value for rational drug design. Unfortunately, in practice, the approach has not proved to be very rewarding and virtually all useful drugs against cestodes have been developed empirically rather than rationally. The chemotherapy of cestodes will not be covered here as this aspect has been comprehensively reviewed (113, 114, 190, 735, 895, 946). [Pg.77]

Linear and non-linear correlations of structural parameters and strain energies with various molecular properties have been used for the design of new compounds with specific properties and for the interpretation of structures, spectra and stabilities 661. Quantitative structure-activity relationships (QSAR) have been used in drug design for over 30 years 2881 and extensions that include information on electronic features as a third dimension (the electron topological approach, ET) have been developed and tested 481 (see Section 2.3.5). Correlations that are used in the areas of electron transfer, ligand field properties, IR, NMR and EPR spectroscopy are discussed in various other Chapters. Here, we will concentrate on quantitative structure-property relationships (QSPR) that involve complex stabilities 124 289-2911. [Pg.115]

A program wherein pharmaceuticals can be purchased only from the manufacturer or a designated pharmacy. These programs are usually developed for drugs that require extensive monitoring or patient education due to safety concerns. [Pg.165]

Extensive use has been tnade of semiempirieal methods in drug design. " Calculations of the highc.si occupied MO and lowe.st unoccupied MO IHOMO/LUMO) energies for a series of active and inactive compounds have been used as de.scriptors for QSAR. AMI. for example, has recently been used to develop a predictive ADME model for P-450 oxidation of drugs, which is di.scu.sscd below. [Pg.938]


See other pages where Drug design/development extension is mentioned: [Pg.351]    [Pg.7]    [Pg.235]    [Pg.384]    [Pg.138]    [Pg.5]    [Pg.6]    [Pg.376]    [Pg.26]    [Pg.172]    [Pg.1]    [Pg.91]    [Pg.89]    [Pg.666]    [Pg.589]    [Pg.530]    [Pg.559]    [Pg.571]    [Pg.31]    [Pg.221]    [Pg.177]    [Pg.205]    [Pg.223]    [Pg.63]    [Pg.188]    [Pg.179]    [Pg.9]    [Pg.1722]    [Pg.714]    [Pg.1362]    [Pg.35]    [Pg.726]    [Pg.251]    [Pg.13]    [Pg.196]    [Pg.14]    [Pg.28]    [Pg.1016]    [Pg.105]    [Pg.125]    [Pg.163]    [Pg.216]    [Pg.1239]    [Pg.327]    [Pg.31]    [Pg.120]   
See also in sourсe #XX -- [ Pg.243 , Pg.266 , Pg.270 ]




SEARCH



Drug design/development

Drug extension

© 2024 chempedia.info